compound 21k [PMID: 34985886]   Click here for help

GtoPdb Ligand ID: 11833

Compound class: Synthetic organic
Comment: Compound 21k was designed as an inhibitor of TRAF2 and NCK interacting kinase (TNIK) [1]. Inhibition of TNIK is proposed as a mechanism to combat dysregulated Wnt/β-catenin signalling in colorectal cancer.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 58.22
Molecular weight 387.14
XLogP 4.71
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Fc1ccc(cc1)CN1CCOc2c(C1=O)ccc(c2)c1cnc2c(c1)cc[nH]2
Isomeric SMILES O=C1c2ccc(c3cc4cc[nH]c4nc3)cc2OCCN1Cc1ccc(F)cc1
InChI InChI=1S/C23H18FN3O2/c24-19-4-1-15(2-5-19)14-27-9-10-29-21-12-16(3-6-20(21)23(27)28)18-11-17-7-8-25-22(17)26-13-18/h1-8,11-13H,9-10,14H2,(H,25,26)
InChI Key UVLOISNMRLZTPF-UHFFFAOYSA-N
Bioactivity Comments
Potential off-target kinases include Flt4 (IC50 30 nM), Flt1 (IC50 191 nM), DRAK1 (IC50 441 nM) and Aurora A (IC50 517 nM) [1]. Compound 21k is active in vitro and produces antitumour activity in the HCT116 xenograft mouse model of colorectal cancer.
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
TRAF2 and NCK interacting kinase Hs Inhibitor Inhibition 7.6 pIC50 - 1
pIC50 7.6 (IC50 2.6x10-8 M) [1]